When I started my placement at Pharmora, I assumed medical monitoring and pharmacovigilance were just two names for the same thing: keeping an eye on patient safety. However after a few conversations with the team it became clear that they are two distinct disciplines that sit at different points along the “bench to bedside” drug development pipeline. Medical monitoring belongs to a single clinical trial, while pharmacovigilance, also known as patient safety or drug safety, follows a medicine for its whole life. Understanding that distinction changed how I think about what keeping patients safe actually means.

Medical monitoring turned out to be much more hands-on than I expected. Clinical Research Associates visit trial sites or work remotely to carry out Source Data Verification, checking for discrepancies between the trial database and original patient records. Alongside this, teams carry out global data review across an entire study’s dataset, as well as individual patient reviews, looking for outliers which may suggest errors or adverse events. Medical monitors also make sure investigators are trained to use Toxicity Management Guidance correctly, which is interestingly written by the pharmacovigilance team, highlighting that safety expertise isn’t confined to one discipline, but built into the trial from multiple angles.

Pharmacovigilance (PV) takes a wider view. Rather than watching one trial, it pools safety data from every ongoing study of a drug and from real-world use once a medicine reaches patients commercially. This matters because some risks are invisible at a smaller scale: rare and long-term side effects only emerge once data is combined across many sources. This is where activities like signal management come in, verifying causal association with adverse events, and submitting evidence to regulatory agencies. Action is then taken, updating the prescribing information, aimed at healthcare professionals for effective drug administration. PV doesn’t just watch a drug; it continuously updates that drug’s safety profile, at a global scale, for as long as it’s on the market.

What surprised me most was how much these two disciplines depend on each other. Medical monitoring continuously protects the patients in one study; pharmacovigilance is what stops rare or long-term risks slipping through once the medicine moves from a controlled trial to everyday prescribing. Seeing that connection has changed how I think about the whole pharmacological pipeline: not simply from bench to bedside, but the continuous thread of safety oversight that runs through it.

Please follow this link to visit our Home Page and find out more about Pharmora!